Get the Stockscreener App
94.73
0.76%
0.71
After Hours:
94.73
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc Stock (MRK) Latest News
ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK - TradingView
The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 – MRK - GlobeNewswire Inc.
Merck & Co., Inc. (MRK): Among Incredibly Cheap Dividend Stock to Buy Now - Insider Monkey
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - GlobeNewswire
Why Merck & Co. (MRK) Is Among the Most Undervalued Biotech Stocks to Invest In - Yahoo Finance
Merck & Co., Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your RightsMRK - ACCESS Newswire
MRK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - Markets Insider
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
Merck & Co's Options: A Look at What the Big Money is Thinking - Benzinga
Class Action Filed Against Merck & Co., Inc. (MRK)April 14, 2025 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued S&P 500 Stock to Buy Now? - Yahoo Finance
Levi & Korsinsky Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025MRK - PR Newswire
Is Merck & Co Inc. (NYSE:MRK) the Most Profitable Value Stock to Buy Now? - Insider Monkey
Shareholders that lost money on Merck & Co., Inc.(MRK) - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming DeadlinesMRK - PR Newswire
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Merck & Co., Inc. (MRK): Among Top Dividend Contenders List - Yahoo Finance
2025-03-16 | Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NYSE:MRK | Press Release - Stockhouse Publishing
MRK STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., - GlobeNewswire
Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRK - Markets Insider
A Closer Look at Merck & Co's Options Market Dynamics - Benzinga
MRK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Dividend Roundup: Microsoft, Walmart, Target, Merck & Co, and more - Seeking Alpha
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc. (MRK) Shareholders - ACCESS Newswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., - GlobeNewswire
Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.
Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK) - GlobeNewswire
MRK STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Merck & Co., Inc. (NYSE:MRK) Looks Interesting, And It's About To Pay A Dividend - Yahoo Finance
Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025MRK - PR Newswire
Merck & Co.’s SWOT analysis: pharma giant faces challenges amid keytruda dominance - Investing.com India
Merck & Co., Inc. (NYSE:MRK) Receives $116.39 Consensus Target Price from Analysts - Defense World
Kelun Wins World’s First TROP2 ADC Approval In Lung Cancer, Merck Left Out - Citeline News & Insights
How Do Investors Really Feel About Merck & Co? - Benzinga
Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds - Insider Monkey
Merck releases positive phase 3 data on daily oral HIV drug (MRK:NYSE) - Seeking Alpha
Merck's Investigational Two-Drug Regimen Maintained HIV-1 Suppression in Late-Stage Trials - Marketscreener.com
Merck: new treatment option for HIV -March 12, 2025 at 12:16 pm EDT - Marketscreener.com
Merck & Co., Inc. (MRK): Among Dobermans of the Dow to Buy - Insider Monkey
Anti-Inflammatory Therapeutics Market to Reach $125.55 Billion by 2028 | Merck & Co., Inc., GlaxoSmithKline - EIN News
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Merck & Co., Inc. to Contact the Firm Today! - Markets Insider
Investors in Merck & Co., Inc. Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your RightsMRK - Stockhouse Publishing
Merck scores victory in Gardasil lawsuits as judge questions evidence - Seeking Alpha
Merck prevails in Gardasil safety litigation -March 11, 2025 at 04:40 pm EDT - Marketscreener.com
Merck prevails in Gardasil safety litigation - Reuters
Merck prevails in Gardasil safety litigation -March 11, 2025 at 04:23 pm EDT - Marketscreener.com
1.48%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):